Dapsone Gel
FDA Label NDC 70771-1538

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Dapsone (NDC 70771-1538). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

Dapsone Gel, 7.5%

60 g

NDC 70771-1538-3

Zydus

Rx only

Dapsone Gel (Ae448df2 611f 4d56 911f 11d01983726f 01)

Dapsone Gel (Ae448df2 611f 4d56 911f 11d01983726f 01)

Dapsone Gel (Ae448df2 611f 4d56 911f 11d01983726f 02)

Dapsone Gel (Ae448df2 611f 4d56 911f 11d01983726f 02)

* Please review the disclaimer below.